RKB Global Limited
₹ 115▼4.17%(5.00)
About the company
Founded in 1932, the company began its journey as a steel commodity trading business and has since grown into a trusted manufacturer and established brand in the steel industry. Decades of experience, combined with a strong commitment to quality and customer satisfaction, have helped it build a solid reputation across diverse industrial sectors.
To support growing demand and maintain consistent product standards, the company operates modern manufacturing facilities in Maharashtra and Gujarat. These advanced plants are equipped with efficient production technologies and stringent quality control processes, enabling the company to deliver reliable steel products that meet evolving industry requirements.
Fundamentals
Valuation
- 52 week high
- ₹128
- 52 week low
- ₹115
- P/B ratio
- 2.37
- Debt to equity
- 0.29
- ROE (%)
- 5.42%
- Book value
- ₹48.61
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE028W01017
Figures in cr
Financials
| P&L Statement | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 385 | 368 | 360 | 457 | 411 |
| EBITDA | 7 | 16 | 17 | 30.38 | 30 |
| OPM | 1.82 | 4.35 | 4.72 | 6.65 | 7.3 |
| PBT | 4 | 4 | 8 | 10.71 | 15 |
| PAT | 3 | 3 | 6 | 8.04 | 11 |
| EPS | 1.56 | 1.04 | 2.07 | 2.05 | 2.51 |
Shareholding Pattern
Leadership
Frequently asked questions
Common questions on RKB Global Limited—tap a row to read the answer.
Q.1What does RKB Global Limited do?
RKB Global Limited is engaged in the steel industry, with a business spanning manufacturing, branding, and the supply of a wide range of steel products. Over the years, the company has expanded its operations through modern manufacturing facilities and a focus on product innovation to serve various industrial sectors.
Q.2How can I buy RKB Global Limited unlisted shares?
To buy RKB Global Limited unlisted shares, you typically need an active Demat account and PAN-linked KYC. After identifying a seller and agreeing on the price, the shares are transferred to your Demat account once the transaction is completed and verified. Always ensure that you deal through a reliable and compliant transaction process.
Q.3Can I sell my RKB Global Limited unlisted shares before the company gets listed?
Yes. Unlisted shares can generally be sold before a public listing by finding a willing buyer. Since these shares are traded privately rather than on stock exchanges, the transaction is completed through an off-market transfer after both parties agree on the terms.
Q.4Is there a lock-in period for RKB Global Limited unlisted shares?
For most secondary-market purchases of unlisted shares, there is generally no mandatory lock-in period. However, if the company is listed in the future, regulatory lock-in rules may apply depending on the nature of the shares and applicable SEBI regulations at that time.
Q.5What factors influence the price of RKB Global Limited unlisted shares?
The value of RKB Global Limited unlisted shares can be influenced by several factors, including the company's financial performance, revenue growth, profitability, business expansion, industry outlook, investor demand, and any significant corporate developments or future listing expectations.
Q.6What is the minimum investment required in RKB Global Limited?
There is no fixed minimum investment amount. The investment depends on the availability of shares, the negotiated price per share, and the minimum quantity offered by the seller. The total investment may therefore vary from one transaction to another.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
